HAART Standard Version of the PROMISE Study
(Promoting Maternal and Infant Survival Everywhere)
A randomized trial that will screen and recruit pregnant or postpartum women on HIV medications for prevention of mother-to-child transmission of HIV. The study will see if it is better for the health of the woman if she continues HIV medications or stops after delivery as is currently done.
Eligible participants will be randomized within 28 days postpartum to one of two study arms:
- Arm A=Continuing HIV meds postpartum
- Arm B=Stopping HIV meds postpartum; but will be returned to HIV meds if she medically needs them.
Women will be followed until 84 weeks after the last woman is enters the study; which could be up to 5.75 years total.